col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Newlands Press Ltd: Bioanalysis
  original article Date Title Authors   All Authors
1 [GO] 2021―Sep―13 Deploying a rapid point of care polymerase chain reaction test for SARS-CoV-2 in a clinical research unit to ensure healthy volunteer safety Radboud van Trigt, Jason Neat, Jan Leendert Brouwer, Amanda Hays, Hans Westerhof
2 [GO] 2021―Aug―31 Volumetric absorptive microsampling: its use in COVID-19 research and testing James Rudge, Stuart Kushon
3 [GO] 2021―Aug―31 A minireview on nanoparticle-based sensors for detection of coronaviruses Elaheh Rahimpour, Farzaneh Lotfipour, Abolghasem Jouyban
4 [GO] 2021―Aug―18 Special Focus Issue - COVID-19: bioanalytical considerations, contributions and lessons - part 1 Sankeetha Nadarajah
5 [GO] 2021―Aug―10 COVID-19’s impact on bioanalytical labs Amy Lavelle, Janine Micheli
6 [GO] 2021―Aug―06 Efficiency of pooled surveillance testing in academic labs to detect and inhibit COVID-19 outbreaks John C Sitko, James Jordan Steel, Erin A Almand, Christopher A Cullenbine, Joseph W Rohrer, Douglas P Wickert, Steven CM Hasstedt
7 [GO] 2021―Jul―22 Detection of SARS-CoV-2 at the point of care Michael J Loeffelholz, Yi-Wei Tang
8 [GO] 2021―Jul―21 Rapid diagnostics for SARS-CoV-2 virus: point-of-care testing and lessons learned during the pandemic Trieu Nguyen, Anders Wolff
9 [GO] 2021―Jul―19 How the COVID-19 pandemic is changing clinical trial conduct and driving innovation in bioanalysis Melanie Anderson
10 [GO] 2021―Jul―19 Lessons learned from the COVID pandemic and its impact on bioanalysis and drug development Enaksha R Wickremsinhe, Catherine L Brockus, Anthony T Murphy
11 [GO] 2021―Feb―04 Adaptation of Elecsys® anti-severe acute respiratory syndrome coronavirus-2 immunoassay to dried blood spots: proof of concept Alexandre Marchand, Ingrid Roulland, Florian Semence, Magnus Ericsson
12 [GO] 2021―Jan―11 Key points of technical review for the registration of SARS-CoV-2 antigen/antibody tests Hongran Li, Jingyun He, Wen Bao, Peirong Wang, Yunfeng Lv, Chao Xu, et al. (+6)
13 [GO] 2020―Dec―16 China NMPA perspective on clinical evaluation of SARS-CoV-2 antibody test reagents in the process of emergency approval Yunfeng Lv, Jingyun He, Rongzhi Liu, Yu Gao, Chao Xu, Peng Hu, et al. (+6)
14 [GO] 2020―Dec―15 Validation of dried blood spot sample modifications to two commercially available COVID-19 IgG antibody immunoassays Theodore T Zava, David T Zava
15 [GO] 2020―Sep―11 How ADA methodology informs SARS-CoV-2 assay development Caroline Becker
16 [GO] 2020―Aug―21 Safety considerations in the bioanalytical laboratories handling specimens from coronavirus disease 2019 patients Zhuo Chen, Timothy W Sikorski
17 [GO] 2020―Jul―31 Could breath analysis by MS could be a solution to rapid, non-invasive testing for COVID-19? Heather J Walker, Michael M Burrell
18 [GO] 2020―Jun―26 Bioanalytical research and training in academia during the COVID-19 pandemic Frank Klont, Gérard Hopfgartner
19 [GO] 2020―Jun―23 Laboratory considerations amidst the coronavirus disease 2019 outbreak: the Spedali Civili in Brescia experience Emirena Garrafa, Duilio Brugnoni, Mosè Barbaro, Laura Andreoli, Emanuele Focà, Massimo Salvetti, et al. (+6)
20 [GO] 2020―Jun―12 Virtual drug testing: redefining sample collection in a global pandemic Matthew N Fedoruk
21 [GO] 2020―May―26 Rapid and robust bioanalytical assays are critical for SARS-CoV-2 therapeutic and vaccine development and beyond Sumit Kar, Rafiqul Islam
22 [GO] 2020―Apr―15 Exhaled breath condensate as a potential specimen for diagnosing COVID-19 Maryam Khoubnasabjafari, Vahid Jouyban-Gharamaleki, Reza Ghanbari, Abolghasem Jouyban
23 [GO] 2020―Apr―14 Managing bioanalytical studies during the COVID-19 pandemic: an overview Peter Pruim, Naomi Teekamp


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.008 sec